Last Updated:
Searching
Create account to add to watchlist!

Periphas Capital Partnering Corp - PCPC

  • Commons

    $24.33

    -0.45%

    PCPC Vol: 369.0

  • Warrants

    $1.86

    +5.08%

    PCPC+ Vol: 0.0

  • Units

    $24.75

    -0.40%

    PCPC= Vol: 50.0

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 408.9M
Average Volume: 13.7K
52W Range: $23.35 - $26.49
Weekly %: -0.57%
Monthly %: -0.69%
Inst Owners: 63

Info

Target: Searching
Days Since IPO: 353
Unit composition:
of
Trust Size: 30000000.0M

🕵Stocktwit Mentions

T8skmod posted at 2021-11-26T02:55:35Z

$PCPC Twits Stats Today's Change 23% + 🚀 https://t8sk.com/PCPC

Tickstocks posted at 2021-11-24T00:35:05Z

$PCPC Twits Stats Today's Change 23% + 🚀 https://t8sk.com/PCPC

Last10K posted at 2021-11-12T22:38:20Z

$PCPC just filed a 10-Q Quarterly Report with 34 sections and 4 exhibits. Access them all or just read their earnings: https://last10k.com/sec-filings/pcpc/0001193125-21-328206.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=10KQ2040F&utm_term=pcpc

cctranscripts posted at 2021-11-12T22:17:21Z

Periphas Capital Partnering Corp Just Filed Its Quarterly Report: Net Income (Loss) Pe... https://www.conferencecalltranscripts.com/summary/?id=10104514 $PCPC

risenhoover posted at 2021-11-12T21:49:19Z

$PCPC / Periphas Capital Partnering files form 10-Q https://fintel.io/sf/us/pcpc?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filing

Quantisnow posted at 2021-11-12T21:48:38Z

$PCPC 📜 SEC Form 10-Q filed by Periphas Capital Partnering Corporation https://quantisnow.com/insight/2003154?s=s 45 seconds delayed.

Newsfilter posted at 2021-11-12T21:47:54Z

$PCPC Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC https://newsfilter.io/a/06e2413e3a20620c46eea5075586749d

Grade1View posted at 2021-11-06T03:30:33Z

$PCPC 2 commons and 52,822 warrants purchased today (equivalent to 132,055 in a normally priced spac) looks like someone(s?) wanted a nice big warrant position and bought a common or 2 to keep track of any action. I’m so interested to see price action here with this structure if/when a deal gets announced.

Grade1View posted at 2021-10-23T01:32:45Z

$PCPC These warrants are hard to pick up but they are trading at the equivalent of 0.57 (1.44 / 2.5). Ive been adding an extra couple hundred here and there when orders fill. they did not get chased up today during warrant speculation hype probably due to lack of awareness of the structure. Admittedly, I sold all but 10,000 $ENPC units from my account but both of these have the CAPS structure despite enpc doing the split to bring price back to $10 for nav.

Tickstocks posted at 2021-10-13T03:23:45Z

$PCPC Tweet Stats Today's Change 23% 🚀 + https://t8sk.com/PCPC

Tickstocks posted at 2021-09-24T10:57:23Z

$PCPC Tweet Stats Today's Change 23% 🚀 + https://t8sk.com/PCPC

T8skmod posted at 2021-09-07T18:56:29Z

$PCPC Tweet Stats Today's Change 23% + https://t8sk.com/PCPC

Tickstocks posted at 2021-09-05T00:10:14Z

$PCPC Tweet Stats Today's Change 23% + https://t8sk.com/PCPC

Last10K posted at 2021-08-13T12:22:31Z

$PCPC just filed a 10-Q Quarterly Report with 30 sections and 4 exhibits. Access them all or just read their earnings: https://last10k.com/sec-filings/pcpc/0001193125-21-245451.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=10KQ2040F&utm_term=pcpc

cctranscripts posted at 2021-08-13T12:22:07Z

Periphas Capital Partnering Corp Just Filed Its Quarterly Report: Net Income (Loss) Pe... https://www.conferencecalltranscripts.com/summary/?id=9769646 $PCPC

Quantisnow posted at 2021-08-13T12:21:15Z

$PCPC 📜 SEC Form 10-Q filed by Periphas Capital Partnering Corporation https://quantisnow.com/insight/1666550?s=s 30s delayed.

risenhoover posted at 2021-08-13T12:17:32Z

$PCPC / Periphas Capital Partnering files form 10-Q https://fintel.io/sf/us/pcpc?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filing

Newsfilter posted at 2021-08-13T12:17:06Z

$PCPC Form 10-Q (quarterly report [sections 13 or 15(d)]) filed with the SEC https://newsfilter.io/a/ce5c0abe24233ec18e1b2ef1bf184e7e

T8skmod posted at 2021-08-07T06:42:34Z

$PCPC Tweet Stats Today's Change 23% + https://t8sk.com/PCPC

tickeron posted at 2021-08-01T20:30:22Z

How do you think the market will react to this? $PCPC in -0.58% Downtrend, sliding for three consecutive days on July 14, 2021. View odds for this and other indicators: https://srnk.us/go/2922875

tickeron posted at 2021-07-31T09:49:24Z

What do you think of this? $PCPC in -0.58% Downtrend, declining for three consecutive days on July 14, 2021. View odds for this and other indicators: https://srnk.us/go/2919399

tickeron posted at 2021-07-30T14:09:08Z

Are the daytraders watching this? $PCPC in -0.58% Downtrend, declining for three consecutive days on July 14, 2021. View odds for this and other indicators: https://srnk.us/go/2917384

tickeron posted at 2021-07-25T21:15:22Z

Good move or bad move? $PCPC in -0.58% Downtrend, sliding for three consecutive days on July 14, 2021. View odds for this and other indicators: https://srnk.us/go/2905777

T8SK1 posted at 2021-07-25T01:18:42Z

$PCPC Tweet Trends Today's Change 23 % + https://t8sk.com/PCPC

T8SK1 posted at 2021-07-20T05:47:19Z

$PCPC Tweet Trends Today's Change 23 % + https://t8sk.com/PCPC

Soda_Popinski posted at 2021-07-16T19:44:43Z

$PCPC my spac warrant portfolio is deep red except for this one thats up 20%. Yet this board is dead and nothing can be found on this one online 🤨

T8SK1 posted at 2021-07-10T19:02:25Z

$PCPC Tweet Trends Today's Change 23 % + https://t8sk.com/PCPC

T8SK1 posted at 2021-07-07T21:36:07Z

$PCPC Tweet Trends Today's Change 23 % + https://t8sk.com/PCPC

Soda_Popinski posted at 2021-07-07T21:08:13Z

$PCPC 117 volume here today and we up 1.50% wow things are heating up !

tickeron posted at 2021-06-29T18:21:14Z

Are the daytraders watching this? $PCPC enters a Downtrend because Momentum Indicator dropped below the 0 level on June 25, 2021. View odds for this and other indicators: https://srnk.us/go/2841862

Management

Officers, Directors and Director Nominees.” Our officers, directors and operating partners presently have, and any of them in the future may have additional, fiduciary or contractual obligations to other entities and, accordingly, may have conflicts of interest in determining to which entity a particular business opportunity should be presented. Following the completion of this offering and until we consummate our partnering transaction, we intend to engage in the business of identifying and combining with one or more businesses. Each of our officers and directors presently has, and any of them in the future may have, additional fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present a partnering transaction opportunity to such entity. Accordingly, they may have conflicts of interest in determining to which entity a particular business opportunity should be presented. These conflicts may not be resolved in our favor and a potential partnering candidate may be presented to another entity prior to its presentation to us. Our amended and restated certificate of incorporation will provide that we renounce our interest in any corporate opportunity offered to any director or officer unless such opportunity is expressly offered to such person solely in his or her capacity as a director or officer of the company and such opportunity is one we are legally and contractually permitted to undertake and would otherwise be reasonable for us to pursue, and to the extent the director or officer is permitted to refer that opportunity to us without violating another legal obligation. For a complete discussion of our executive officers’ and directors’ business affiliations and the potential conflicts of interest that you should be aware of, please see “Management — Officers, Directors and Director Nominees,” “Conflicts of Interest” and “Certain Relationships and Related Party Transactions.” Our executive officers, directors, security holders, operating partners and their respective affiliates may have competitive pecuniary interests that conflict with our interests. We have not adopted a policy that expressly prohibits our directors, executive officers, security holders, operating partners or affiliates from having a direct or indirect pecuniary or financial interest in any investment to be acquired or disposed of by us or in any transaction to which we are a party or have an interest. In fact, we may enter into a partnering transaction with a partnering candidate that is affiliated with our sponsor, our directors, executive officers or operating partners, although we do not intend to do so, or we may acquire a partnering candidate through an affiliated joint acquisition with one or more affiliates of Periphas Capital and/or one or more investors in Periphas Capital or one of its affiliates. Nor do we have a policy that expressly prohibits any such persons from engaging for their own account in business activities of the types conducted by us. Accordingly, such persons or entities may have a conflict between their interests and ours. The personal and financial interests of our directors, officers and operating partners may influence their motivation in timely identifying and selecting a partnering candidate and completing a partnering transaction. Consequently, our directors’ and officers’ discretion in identifying and selecting a suitable partnering candidate may result in a conflict of interest when determining whether the terms, conditions and timing of a particular partnering transaction are appropriate and in our stockholders’ best interest. If this were the case, it would be a breach of their fiduciary duties to us as a matter of Delaware law and we or our stockholders might have a claim against such individuals for infringing on our stockholders’ rights. However, we might not ultimately be successful in any claim we may make against them for such reason. 42 Table of Contents We may engage in a partnering transaction with one or more partnering candidates that have relationships with entities that may be affiliated with our sponsor, executive officers, directors, operating partners or existing holders which may raise potential conflicts of interest. In light of the involvement of our sponsor, executive officers, operating partners and directors with other entities, we may decide to acquire one or more businesses affiliated with our sponsor, executive officers, directors, operating partners or existing holders. Our directors also serve as officers and board members for other entities, including, without limitation, those described under “Management — Conflicts of Interest.” Such entities may compete with us for partnering transaction opportunities. Our sponsor, officers and directors are not currently aware of any specific opportunities for us to complete our partnering transaction with any entities with which they are affiliated, and there have been no substantive discussions concerning a partnering transaction with any such entity or entities. Although we will not be specifically focusing on, or targeting, any transaction with any affiliated entities, we would pursue such a transaction if we determined that such affiliated entity met our criteria for a partnering transaction as set forth in “Proposed Business — Effecting our Partnering Transaction” and such transaction was approved by a majority of our independent and disinterested directors. Despite our agreement to obtain an opinion from an independent investment banking firm or an independent accounting firm regarding the fairness to our company from a financial point of view of a partnering transaction with one or more domestic or international businesses affiliated with our sponsor, executive officers, directors, operating partners or existing holders, potential conflicts of interest still may exist and, as a result, the terms of the partnering transaction may not be as advantageous to our public stockholders as they would be absent any conflicts of interest. Moreover, we may pursue an affiliated joint acquisition opportunity with one or more affiliates of Periphas Capital and/or one or more investors in Periphas Capital or one of its affiliates. Any such parties may co-invest with us in the partnering candidate at the time of our partnering transaction, or we could raise additional proceeds to complete the partnering transaction by issuing to such parties a class of equity or equity-linked securities. Accordingly, such persons or entities may have a conflict between their interests and ours. Since our sponsor, executive officers and directors will lose their entire investment in us if our partnering transaction is not completed (other than with respect to public shares they may acquire during or after this offering), a conflict of interest may arise in determining whether a particular partnering candidate is appropriate for our partnering transaction. On September 14, 2020, our sponsor purchased an aggregate of (a) 690,000 founder shares in exchange for a capital contribution of $6,250, or approximately $0.01 per share and (b) 120,000 performance shares for a capital contribution of $18,750, or $0.156 per share. The purchase price of the founder shares was determined by dividing the amount of cash contributed to the company by the number of founder shares issued. The number of founder shares outstanding was determined based on the expectation that the total size of this offering would be a maximum of 13,800,000 CAPSTM if the underwriter’s over-allotment option is exercised in full, and therefore that such founder shares would represent 5% of the outstanding shares of Class A common stock (not including the private placement shares) issued in this offering. Up to 90,000 of our sponsor’s founder shares will be forfeited depending on the extent to which the underwriter’s over-allotment is exercised. The founder shares will be worthless if we do not complete a partnering transaction. In addition, our sponsor has committed to purchase an aggregate of 200,000 private placement CAPSTM (or 218,000 private placement CAPSTM if the underwriter’s over-allotment option is exercised in full), for an aggregate purchase price of $5,000,000 (or $5,450,000 if the underwriter’s over-allotment option is exercised in full), or $25.00 per private placement CAPSTM. The 50,000 warrants underlying such private placement CAPSTM (or 54,500 warrants if the underwriter’s over-allotment option is exercised in full) will also be worthless if we do not complete our partnering transaction. The personal and financial interests of our executive officers and directors may influence their motivation in identifying and selecting a partnering transaction, completing a partnering transaction and influencing the operation of the business following the partnering transaction. This risk may become more acute as the 24-month anniversary of the closing of this offering nears, which is the deadline for our completion of a partnering transaction. 43 Table of Contents We may issue notes or other debt securities, or otherwise incur substantial debt, to complete a partnering transaction, which may adversely affect our leverage and financial condition and thus negatively impact the value of our stockholders’ investment in us. Although we have no commitments as of the date of this prospectus to issue any notes or other debt securities, or to otherwise incur outstanding debt following this offering, we may choose to incur substantial debt to complete our partnering transaction. We and our officers have agreed that we will not incur any indebtedness unless we have obtained from the lender a waiver of any right, title, interest or claim of any kind in or to the monies held in the trust account. As such, no issuance of debt will affect the per share amount available for redemption from the trust account. Nevertheless, the incurrence of debt could have a variety of negative effects, including: • default and foreclosure on our assets if our operating revenues after a partnering transaction are insufficient to repay our debt obligations; • acceleration of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant; • our immediate payment of all principal and accrued interest, if any, if the debt is payable on demand; • our inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while the debt is outstanding; • our inability to pay dividends on shares of our Class A common stock; • using a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends on shares of our Class A common stock if declared, expenses, capital expenditures, acquisitions and other general corporate purposes; • limitations on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; • increased vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation; and • limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements, execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt. We may only be able to complete one partnering transaction with the proceeds of this offering, the sale of the private placement CAPSTM, which will cause us to be solely dependent on a single business which may have a limited number of products or services. This lack of diversification may negatively impact our operations and profitability. The net proceeds from this offering and the private placement of CAPSTM will provide us with $300,000,000 (or $345,000,000 if the underwriter’s over-allotment option is exercised in full) that we may use to complete our partnering transaction. We may effectuate our partnering transaction with a single partnering candidate or multiple partnering candidates simultaneously or within a short period of time. However, we may not be able to effectuate our partnering transaction with more than one partnering candidate because of various factors, including the existence of complex accounting issues and the requirement that we prepare and file pro forma financial statements with the SEC that present operating results and the financial condition of several partnering candidates as if they had been operated on a combined basis. By completing our partnering transaction with only a single entity, our lack of diversification may subject us to numerous economic, competitive and regulatory developments. Further, we would not be able to diversify our operations or benefit from the possible 44 Table of Contents spreading of risks or offsetting of losses, unlike other entities which may have the resources to complete several partnering transactions in different industries or different areas of a single industry. Accordingly, the prospects for our success may be: • solely dependent upon the performance of a single business, property or asset, or • dependent upon the development or market acceptance of a single or limited number of products, processes or services. This lack of diversification may subject us to numerous economic, competitive and regulatory risks, any or all of which may have a substantial adverse impact upon the particular industry in which we may operate subsequent to our partnering transaction. We may attempt to simultaneously complete partnering transactions with multiple prospective partnering candidates, which may hinder our ability to complete our partnering transaction and give rise to increased costs and risks that could negatively impact our operations and profitability. If we determine to simultaneously acquire several businesses that are owned by different sellers, we will need for each of such sellers to agree that our purchase of its business is contingent on the simultaneous closings of the other partnering transactions, which may make it more difficult for us, and delay our ability, to complete our partnering transaction. With multiple partnering transactions, we could also face additional risks, including additional burdens and costs with respect to possible multiple negotiations and due diligence investigations (if there are multiple sellers) and the additional risks associated with the subsequent assimilation of the operations and services or products of the acquired companies in a single operating business. If we are unable to adequately address these risks, it could negatively impact our profitability and results of operations. We may attempt to complete our partnering transaction with a private company about which little information is available, which may result in a partnering transaction with a company that is not as profitable as we suspected, if at all. In pursuing our partnering transaction strategy, we may seek to effectuate our partnering transaction with a privately held company. Very little public information generally exists about private companies, and we could be required to make our decision on whether to pursue a potential partnering transaction on the basis of limited information, which may result in a partnering transaction with a company that is not as profitable as we suspected, if at all. We do not have a specified maximum redemption threshold. The absence of such a redemption threshold may make it possible for us to complete our partnering transaction with which a substantial majority of our stockholders or warrant holders do not agree. Our amended and restated certificate of incorporation does not provide a specified maximum redemption threshold, except that in no event will we redeem our public shares in an amount that would cause our net tangible assets to be less than $5,000,001. In addition, our proposed partnering transaction may impose a minimum cash requirement for: (i) cash consideration to be paid to the partnering candidate or its owners, (ii) cash for working capital or other general corporate purposes or (iii) the retention of cash to satisfy other conditions. As a result, we may be able to complete our partnering transaction even though a substantial majority of our public stockholders do not agree with the transaction and have redeemed their shares or, if we seek stockholder approval of our partnering transaction and do not conduct redemptions in connection with our partnering transaction pursuant to the tender offer rules, have entered into privately negotiated agreements to sell their shares to our sponsor, officers, directors, operating partners, advisors or any of their affiliates. In the event the aggregate cash consideration we would be required to pay for all shares of Class A common stock that are validly submitted for redemption plus any amount required to satisfy cash conditions 45 Table of Contents pursuant to the terms of the proposed partnering transaction exceed the aggregate amount of cash available to us, we will not complete the partnering transaction or redeem any shares in connection with such partnering transaction, all shares of Class A common stock submitted for redemption will be returned to the holders thereof, and we instead may search for an alternate partnering transaction. In order to effectuate a partnering transaction, special purpose acquisition companies have, in the recent past, amended various provisions of their charters and other governing instruments, including their warrant agreements. We cannot assure you that we will not seek to amend our amended and restated certificate of incorporation or governing instruments in a manner that will make it easier for us to complete our partnering transaction that our stockholders may not support. In order to effectuate a partnering transaction, special purpose acquisition companies have, in the recent past, amended various provisions of their charters and governing instruments, including their warrant agreements. For example, special purpose acquisition companies have amended the definition of partnering transaction, increased redemption thresholds and extended the time to consummate a partnering transaction and, with respect to their warrants, amended their warrant agreements to require the warrants to be exchanged for cash and/or other securities. Amending certain provisions of our amended and restated certificate of incorporation will require the approval of holders of 60% of the voting power of our common stock, and amending our warrant agreement will require a vote of holders of at least 50% of the public warrants that vote on such amendment and, solely with respect to any amendment to the terms of the private placement CAPSTM or any provision of the warrant agreement with respect to the private placement CAPSTM, 50% of the number of the then outstanding private placement CAPSTM. In addition, our amended and restated certificate of incorporation requires us to provide our public stockholders with the opportunity to redeem their public shares for cash if we propose an amendment to our amended and restated certificate of incorporation to modify the substance or timing of our obligation to redeem 100% of our public shares if we do not complete a partnering transaction within 24 months (or 27 months, as applicable) of the closing of this offering or with respect to any other material provisions relating to stockholders’ rights or pre-partnering transaction activity. To the extent any of such

Holder Stats

1 0
% of Shares Held by All Insider 1.46%
% of Shares Held by Institutions 73.40%
% of Float Held by Institutions 74.49%
Number of Institutions Holding Shares 63

Mutual Fund Holders

Holder Shares Date Reported Value % Out
Franklin K2 Alternative Strategies Fd 10736 2021-02-27 268507 0.06

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2021-11-16 Schonfeld Strategic Advisors LLC 35,000 $850,000 0.0% +24.8% 0.208%
2021-11-15 Alberta Investment Management Corp 114,644 $2,790,000 0.0% -20.0% 0.682%
2021-11-15 Berkley W R Corp 21,054 $510,000 0.0% +5.9% 0.125%
2021-11-12 Weiss Asset Management LP 258,186 $6,290,000 0.2% +3.0% 1.536%
2021-11-12 Hsbc Holdings PLC 100,000 $2,450,000 0.0% 0 0.595%
2021-11-04 Corbyn Investment Management Inc. MD 15,008 $370,000 0.1% 0 0.089%
2021-08-17 Beryl Capital Management LLC 339,285 $8,320,000 0.7% +8.9% 2.019%
2021-08-13 Basso Capital Management L.P. 1,031 $25,000 0.0% 0 0.006%
2021-08-11 Susquehanna International Group LLP 9,614 $240,000 0.0% -16.4% 0.057%
2021-08-06 HighTower Advisors LLC 121,762 $2,990,000 0.0% +135.0% 0.725%
2021-05-17 Schonfeld Strategic Advisors LLC 28,037 $670,000 0.0% -29.8% 0.167%
2021-05-17 Brookfield Asset Management Inc. 30,139 $720,000 0.0% -69.9% 0.179%
2021-05-17 Centiva Capital LP 116,305 $2,760,000 0.1% -22.5% 0.692%
2021-05-11 Acadian Asset Management LLC 1,449 $34,000 0.0% 0 0.009%
2021-05-10 HighTower Advisors LLC 51,806 $1,230,000 0.0% 0 0.308%

SEC Filings

Form Type Form Description Filing Date Document Link
10-Q 10-Q 2021-11-12 https://www.sec.gov/Archives/edgar/data/1824993/000119312521328206/d238789d10q.htm
10-Q 10-Q 2021-08-13 https://www.sec.gov/Archives/edgar/data/1824993/000119312521245451/d207078d10q.htm
8-K 8-K 2021-05-28 https://www.sec.gov/Archives/edgar/data/1824993/000119312521177051/d188524d8k.htm
10-Q 10-Q 2021-05-28 https://www.sec.gov/Archives/edgar/data/1824993/000119312521176233/d168451d10q.htm
10-K/A 10-K/A 2021-05-25 https://www.sec.gov/Archives/edgar/data/1824993/000119312521172399/d171330d10ka.htm
8-K 8-K 2021-05-25 https://www.sec.gov/Archives/edgar/data/1824993/000119312521172367/d185403d8k.htm
NT 10-Q NT 10-Q 2021-05-18 https://www.sec.gov/Archives/edgar/data/1824993/000119312521165404/d157175dnt10q.htm
10-K 10-K 2021-03-30 https://www.sec.gov/Archives/edgar/data/1824993/000119312521100445/d106883d10k.htm
SC 13G/A SCHEDULE 13G/A 2021-02-16 https://www.sec.gov/Archives/edgar/data/1824993/000110465921024127/tm214737d29_sc13ga.htm
SC 13G 2021-02-16 https://www.sec.gov/Archives/edgar/data/1824993/000117266121000509/firtree-pcpc123120.htm
SC 13G SC 13G 2021-02-11 https://www.sec.gov/Archives/edgar/data/1824993/000119312521037996/d96803dsc13g.htm
8-K 8-K 2021-01-27 https://www.sec.gov/Archives/edgar/data/1824993/000119312521019243/d36705d8k.htm
SC 13G PERIPHAS CAPITAL PARTNERING CORPORATION 2021-01-25 https://www.sec.gov/Archives/edgar/data/1824993/000090266421000486/p21-0232sc13g.htm
SC 13G SC 13G 2020-12-28 https://www.sec.gov/Archives/edgar/data/1824993/000110465920139747/tm2039430d3_sc13g.htm
SC 13G SC 13G 2020-12-21 https://www.sec.gov/Archives/edgar/data/1824993/000110465920138046/a20-38909_1sc13g.htm
8-K 8-K 2020-12-18 https://www.sec.gov/Archives/edgar/data/1824993/000119312520321700/d92266d8k.htm
SC 13G 2020-12-16 https://www.sec.gov/Archives/edgar/data/1824993/000131924420000192/PCPC_SC13G.htm
4 FORM 4 SUBMISSION 2020-12-16 https://www.sec.gov/Archives/edgar/data/1824993/000089924320034093/xslF345X03/doc4.xml
4 FORM 4 SUBMISSION 2020-12-16 https://www.sec.gov/Archives/edgar/data/1824993/000089924320034091/xslF345X03/doc4.xml
8-K 8-K 2020-12-15 https://www.sec.gov/Archives/edgar/data/1824993/000119312520318130/d99493d8k.htm
3/A FORM 3/A SUBMISSION 2020-12-14 https://www.sec.gov/Archives/edgar/data/1824993/000089924320033795/xslF345X02/doc3a.xml
3/A FORM 3/A SUBMISSION 2020-12-14 https://www.sec.gov/Archives/edgar/data/1824993/000089924320033793/xslF345X02/doc3a.xml
424B4 424B4 2020-12-14 https://www.sec.gov/Archives/edgar/data/1824993/000119312520316045/d30832d424b4.htm
EFFECT 2020-12-09 https://www.sec.gov/Archives/edgar/data/1824993/999999999520003453/xslEFFECTX01/primary_doc.xml
3 FORM 3 SUBMISSION 2020-12-09 https://www.sec.gov/Archives/edgar/data/1824993/000089924320033267/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-12-09 https://www.sec.gov/Archives/edgar/data/1824993/000089924320033265/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-12-09 https://www.sec.gov/Archives/edgar/data/1824993/000089924320033264/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-12-09 https://www.sec.gov/Archives/edgar/data/1824993/000089924320033261/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-12-09 https://www.sec.gov/Archives/edgar/data/1824993/000089924320033259/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-12-09 https://www.sec.gov/Archives/edgar/data/1824993/000089924320033257/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-12-09 https://www.sec.gov/Archives/edgar/data/1824993/000089924320033255/xslF345X02/doc3.xml
3 FORM 3 SUBMISSION 2020-12-09 https://www.sec.gov/Archives/edgar/data/1824993/000089924320033254/xslF345X02/doc3.xml
S-1MEF S-1MEF 2020-12-09 https://www.sec.gov/Archives/edgar/data/1824993/000119312520314074/d30832ds1mef.htm
CERT NYSE CERTIFICATION 2020-12-09 https://www.sec.gov/Archives/edgar/data/1824993/000087666120001132/PCPC120920.pdf
8-A12B 8-A12B 2020-12-09 https://www.sec.gov/Archives/edgar/data/1824993/000119312520313509/d84108d8a12b.htm
S-1/A S-1/A 2020-12-04 https://www.sec.gov/Archives/edgar/data/1824993/000119312520309740/d30832ds1a.htm
S-1/A S-1/A 2020-11-05 https://www.sec.gov/Archives/edgar/data/1824993/000119312520287006/d30832ds1a.htm
S-1 S-1 2020-10-29 https://www.sec.gov/Archives/edgar/data/1824993/000119312520281075/d30832ds1.htm
DRS 2020-09-25 https://www.sec.gov/Archives/edgar/data/1824993/000095012320009960/filename1.htm